Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (161-170 of 200) with videos related to

Pageof 20
Sort By:
European Heart Journal|January 21, 2011
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathyDirk Sibbing, Arne Pfeufer, Tamara Perisic, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
European Heart Journal|March 8, 2023
Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysisJeehoon Kang, Konstantinos D Rizas, Kyung Woo Park, et al.
European Heart Journal|May 20, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
European Heart Journal|October 30, 2016
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on ThrombosisSigrun Halvorsen, Robert F Storey, Bianca Rocca, et al.
Journal of the American College of Cardiology|September 11, 2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.
JAMA|October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysisJessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
European Heart Journal|April 22, 2015
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary interventionDániel Aradi, Ajay Kirtane, Laurent Bonello, et al.
Circulation|July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary SyndromeMarco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions|October 18, 2022
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding RiskShqipdona Lahu, Antonia Presch, Gjin Ndrepepa, et al.
Pageof 20

Showing results (161-170 of 200) with videos related to

Sort By:
Pageof 20
European Heart Journal|January 21, 2011
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathyDirk Sibbing, Arne Pfeufer, Tamara Perisic, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
European Heart Journal|March 8, 2023
Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysisJeehoon Kang, Konstantinos D Rizas, Kyung Woo Park, et al.
European Heart Journal|May 20, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
European Heart Journal|October 30, 2016
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on ThrombosisSigrun Halvorsen, Robert F Storey, Bianca Rocca, et al.
Journal of the American College of Cardiology|September 11, 2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.
JAMA|October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysisJessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
European Heart Journal|April 22, 2015
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary interventionDániel Aradi, Ajay Kirtane, Laurent Bonello, et al.
Circulation|July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary SyndromeMarco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions|October 18, 2022
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding RiskShqipdona Lahu, Antonia Presch, Gjin Ndrepepa, et al.
Pageof 20